Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance.

Saved in:
Bibliographic Details
Title: Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance.
Authors: Schneider, Julia S.1 (AUTHOR) Julia.Schneider@med.uni-muenchen.de, Khaled, Najib Ben1 (AUTHOR), Ye, Liangtao1,2 (AUTHOR), Wimmer, Ralf1 (AUTHOR), Hammann, Linda3 (AUTHOR), Weich, Alexander4 (AUTHOR), Suppan, Christoph5 (AUTHOR), Mahajan, Ujjwal M.1,6 (AUTHOR), Jung, Andreas7 (AUTHOR), Kumbrink, Jörg7 (AUTHOR), Denk, Gerald1 (AUTHOR), Rau, Monika8 (AUTHOR), Kunzmann, Volker9 (AUTHOR), Kuss, Solveig7 (AUTHOR), Neuman, Jens7 (AUTHOR), Mayerle, Julia1 (AUTHOR), Geier, Andreas8 (AUTHOR), Hermanns, Heike M.8 (AUTHOR), De Toni, Enrico N.1 (AUTHOR), Reiter, Florian P.8 (AUTHOR)
Source: Cellular Oncology (2211-3428). Oct2025, Vol. 48 Issue 5, p1363-1375. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-025-01080-7